Holen Sie sich die Stockscreener-App
5.52
2.99%
0.16
Handel nachbörslich:
5.56
0.04
+0.72%
Capsovision Inc Aktie (CV) Neueste Nachrichten
CapsoVision Amends Canon Agreement for Upgraded Image Sensors - TipRanks
CapsoVision increases development fee in amended agreement with Canon - Investing.com UK
Analyzing CapsoVision (CV) and Its Peers - Defense World
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026 - Bitget
AI-enabled capsule endoscopy firm CapsoVision sets March 26 earnings call - Stock Titan
Electronic Pill Market Is Going to Boom Rapidly | Medtronic plc, CapsoVision Inc., IntroMedic Co. Ltd. - openPR.com
CapsoVision to Participate in the 38th Annual ROTH Conference - Bitget
Critical Analysis: CapsoVision (CV) and Its Competitors - Defense World
CapsoVision submits FDA 510(k) for AI-assisted module in CapsoCam Plus - MSN
Reviewing CapsoVision (CV) and Its Rivals - Defense World
CapsoVision, Inc. (NASDAQ:CV) Short Interest Update - Defense World
CapsoVision (CV) & Its Competitors Critical Contrast - Defense World
Critical Survey: CapsoVision (CV) versus Its Rivals - Defense World
Financial Review: CapsoVision (CV) & Its Peers - Defense World
Head-To-Head Contrast: CapsoVision (CV) versus Its Competitors - Defense World
Critical Contrast: CapsoVision (CV) versus Its Rivals - Defense World
Head-To-Head Comparison: CapsoVision (CV) versus The Competition - Defense World
CapsoVision (NASDAQ:CV) and Profusa (NASDAQ:PFSA) Head-To-Head Review - Defense World
CapsoVision (CV) vs. Its Competitors Financial Analysis - Defense World
Reviewing CapsoVision (CV) & Its Competitors - Defense World
Is CapsoVision (NASDAQ:CV) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Head to Head Contrast: CapsoVision (CV) & Its Competitors - Defense World
Contrasting CapsoVision (CV) and The Competition - Defense World
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Increases By 281.0% - MarketBeat
CapsoVision prices $27.5M IPO - MSN
Short Interest in CapsoVision, Inc. (NASDAQ:CV) Declines By 57.4% - MarketBeat
Reviewing Perspective Therapeutics (NASDAQ:CATX) & CapsoVision (NASDAQ:CV) - Defense World
CapsoVision seeks FDA clearance for AI endoscopy module - MSN
Insider-Owned Growth Stocks Poised For Success In January 2026 - simplywall.st
CapsoVision (CV) Price Target Increased by 75.00% to 10.71 - Nasdaq
CapsoVision (NASDAQ:CV) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
CapsoVision Submits 510(k) Application for CapsoCam AI-Assisted Module - Medical Product Outsourcing
CapsoVision price target raised to $14 from $5 at Benchmark - MSN
US Smart Pills Market to Reach US$ 619.10 Million by 2033 | CAGR - openPR.com
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus - Barchart.com
CapsoVision (NASDAQ:CV) Shares Gap DownHere's Why - MarketBeat
CapsoVision, Inc.'s (NASDAQ:CV) Path To Profitability - 富途牛牛
CapsoVision Shares Rise After Company Files 510(k) With US FDA to Add AI-Assisted Module to CapsoCam Plus - MarketScreener
CapsoVision (NASDAQ:CV) Shares Gap UpHere's What Happened - MarketBeat
CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday - Benzinga
CapsoVision Stock Pre-Market (-11%) : FDA 510(k) Submission for AI Module - Trefis
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
CapsoVision submits FDA application for AI-assisted capsule endoscopy By Investing.com - Investing.com Nigeria
CapsoVision submits FDA application for AI-assisted capsule endoscopy - Investing.com
CapsoVision Seeks FDA Clearance for AI Endoscopy Module - TipRanks
CapsoVision Files 510(k) With US FDA to Add AI-Assisted Module to CapsoCam Plus - MarketScreener
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus® - The Manila Times
CapsoVision, Inc Submits 510(k) Application for AI Module - TradingView — Track All Markets
Certain Common Stock of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
Certain Stock Options of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
Certain Warrants of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - MarketScreener
CapsoVision (NASDAQ:CV) Shares Down 6.5% – Time to Sell? - Defense World
CapsoVision, Inc. (NASDAQ:CV) Short Interest Up 171.0% in December - MarketBeat
CapsoVision (NASDAQ:CV) Trading Down 6.5%Here's Why - MarketBeat
CapsoVision (NASDAQ:CV) Trading Up 12.9%Here's Why - MarketBeat
0.66%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):